REMOVED: Two fatal cases of anti-melanoma differentiation-associated gene 5 antibody (anti-MDA5) rapidly progressive interstitial lung disease (RP-ILD): Exploring pitfalls and differences

To address these challenges, early recognition of dermatological indicators, prompt immunosuppressive therapy, and tailored patient management are critical. Additionally, timely referral for extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplantation may improve survival. Advancing research into serum biomarkers holds promise for enhancing diagnostic precision and therapeutic decision-making in RP-ILD.